BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/3/2023 10:22:43 AM | Browse: 465 | Download: 1541
Publication Name World Journal of Clinical Cases
Manuscript ID 84199
Country China
ISSN 2307-8960 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright ©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Urology & Nephrology
Manuscript Type Case Report
Article Title Anti-phospholipase A2 receptor-associated membranous nephropathy with human immunodeficiency virus infection treated with telitacicept: A case report
Manuscript Source Unsolicited Manuscript
All Author List Jin-Ling Wang, Yan-Ling Sun, Zhe Kang, Sheng-Kun Zhang, Chun-Xin Yu, Wan Zhang, Hong-Li Lin and Hua Xie
ORCID
Author(s) ORCID Number
Hong-Li Lin http://orcid.org/0000-0002-6584-9561
Hua Xie http://orcid.org/0000-0003-4971-5333
Funding Agency and Grant Number
Corresponding Author Hong-Li Lin, PhD, Chief Physician, Department of Nephrology, The First Affiliated Hospital of Dalian Medical University, No. 222 Zhongshan Road, Dalian 116000, Liaoning Province, China. linhongli1216@163.com
Key Words Membranous nephropathy; PLA2R; Human immunodeficiency virus; Proteinuria; Telitacicept; Case report
Core Tip The clinical management of anti-phospholipase A2 receptor-associated membranous nephropathy concurrent with human immunodeficiency virus infection presents significant challenges, primarily due to potential unregulated immune responses. In this report, we demonstrated that a weekly subcutaneous injection of telitacicept (160 mg) could ameliorate the 24-h urinary protein levels and enhance serum albumin concentrations, with no discernible impact on T cell counts, showcasing its safety profile.
Publish Date 2023-08-03 10:22
Citation Wang JL, Sun YL, Kang Z, Zhang SK, Yu CX, Zhang W, Lin HL, Xie H. Anti-phospholipase A2 receptor-associated membranous nephropathy with human immunodeficiency virus infection treated with telitacicept: A case report. World J Clin Cases 2023; 5309-5315
URL https://www.wjgnet.com/2307-8960/full/v11/i22/5309.htm
DOI https://dx.doi.org/10.12998/wjcc.v11.i22.5309
Full Article (PDF) WJCC-11-5309-with-cover.pdf
Full Article (Word) WJCC-11-5309.docx